SIGLEC1 and infection: To assess the antiviral immune response, we adoptively transferred ovalbumin-specific CD45.1+ CD8+ T cells from CD45.1 × OT-I transgenic mice to CD45.2 Cd169-cre Ltbrfl/fl and control mice before infection with VSV expressing the ovalbumin (ova) protein.